Gregory Pessin

Gregory E. Pessin is a Partner in Wachtell, Lipton, Rosen & Katz’s Restructuring and Finance Department. He focuses on representing borrowers and issuers with respect to all types of financing for mergers and acquisitions and other corporate transactions and on advising investors in and potential purchasers and sellers of distressed entities.

In the distressed and restructuring space, among other projects, Mr. Pessin has represented Google Inc. as the stalking horse bidder in Nortel Networks’ $4.5 billion sale of its patent assets in a §363 sale in bankruptcy; affiliates of Apollo Management in connection with their acquisition of Aleris International through a pre-negotiated bankruptcy reorganization plan; and the senior secured term lenders to Spectrum Brands, Inc. in a contested bankruptcy in which Spectrum and its junior note holders attempted to reinstate the $1 billion secured term debt facility.

Mr. Pessin has recently been named a “Market Leader” by the IFLR1000 —recognizing him as one of the “true leaders [and] standout performers” in his field and his “track record of high profile innovative deals” —a “Rising Star” in the Insolvency and Restructuring practice area by Expert Guides and a “Rising Star” in the New York metropolitan area by Super Lawyers.

Mr. Pessin received a B.A. from Duke University in 2001, where he was the editor of The Chronicle, the daily independent newspaper of the university community. He received a J.D. with honors from The University of Chicago Law School in 2005, where he was named a member of the Order of the Coif and was a member of The University of Chicago Law Review.

• Thermo Fisher Scientific in connection with committed financing for its pending $11.5 billion acquisition of Qiagen, its $10.6 billion purchase of Fisher Scientific, its $7.2 billion acquisition of Patheon N.V., its $2.1 billion purchase of Dionex and its $13.6 billion acquisition of Life Technologies;
• Cigna with respect to bridge and permanent financing for its $67 billion acquisition of Express Scripts;
• Pfizer with respect to $12 billion of committed bridge financing in connection with the pending $48 billion combination of its off-patent drug business with Mylan;
• Broadcom with respect to $18 billion of committed financing to fund its acquisition of CA, Inc. and $15.5 billion of committed financing to fund its acquisition of the enterprise security business of Symantec Corporation and to refinance certain debt;
• AbbVie on all financing aspects related to its $21 billion acquisition of Pharmacyclics, including with respect to bridge financing commitments and a $16.7 billion senior notes offering;
• salesforce.com in connection with bridge commitments and permanent bank and bond financing for its $6.5 billion acquisition of MuleSoft;
• Kimco Realty Corporation on more than $6 billion of financing transactions;
• Dick’s Sporting Goods on its $475 million issuance of convertible notes;
• XPO Logistics on financing matters arising from its €3.24 billion acquisition of Norbert Dentressangle S.A. and its $3 billion acquisition of Con-way;
• Global Payments on financing matters in connection with its $21.5 billion merger with Total System Services;
• Marlins Holdings in connection with the financing of its acquisition of the Miami Marlins;
• Cabot Microelectronics Corporation on secured high-yield financing to fund its $1.6 billion acquisition of KMG Chemicals, Inc.;
• Penn National Gaming on all financing matters relating to its $2.8 billion acquisition of Pinnacle Entertainment;
• Affiliates of The Carlyle Group on its acquisitions of BenefitsMall, CFGI and Duff & Phelps;
• The J.M. Smucker Company in its issuance of $3.65 billion of senior notes and its entry into a $1.75 billion term loan facility in order to finance its acquisition of Big Heart Pet Brands;
• Tesla in connection with its $2.6 billion acquisition of SolarCity;
• Regency Centers on financing matters in connection with its $15.6 billion combination with Equity One;
• Nasdaq Inc. on a $1.1 billion bridge financing commitment and its issuance of dollar- and euro-denominated senior notes to finance its acquisition of International Securities Exchange;
• PVH in connection with its $3 billion purchase of Tommy Hilfiger and its $3 billion acquisition of Warnaco;
• Agilent Technologies on its spinoff of Keysight Technologies;
• Abbott Laboratories on its spinoff of AbbVie (including with respect to $14.5 billion of senior bank and bridge financings and $14.7 billion of senior notes);
• Motorola Solutions Inc. with respect to its $1 billion issuance of convertible notes to Silver Lake; and
• Cousins Properties on financing issues in its merger with Parkway Properties and simultaneous spin-off of the Houston-based assets of both companies and on its acquisition of Tier Reit.

• Duke University, B.A. 2001
• University of Chicago Law School, 2005, Order of the Coif (The University of Chicago Law Review)